GA
CRSP icon

GoalVest Advisory’s CRISPR Therapeutics CRSP Stock Holding History

GoalVest Advisory’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,132
Closed -$71K – 356
2022
Q1 		$71K Buy
+1,132
New +$71K 0.04% 144